End-to-End Program
Scientific Project Management — We Lead With Your Priorities in Mind
A Seamless Experience, Thanks to Expert Scientific Project Management
From lead candidate selection to clinical proof of concept, whether for a single study or multiple programs, Altasciences’ Scientific Project Management team manages every study with your business priorities in mind.
Join Lauren Szczurowski, Executive Director of Scientific Project Management, in this on-demand podcast as she reveals how Altasciences makes outsourcing early phase drug development a seamless experience.
![Quick Chat - Lauren Szczurowski](/sites/default/files/inline-images/Podcast_thumbnail_Lauren-Szczurowski.jpg)
Schedule a conversation with one of our Scientific Project Managers to review your questions and requirements.
You may also be interested in the following:
- Video: The Benefits of Tell Us Once™
- Video: Your Road to Proactive Development with Altasciences
- Fact Sheet: First-in-Human Trial Capabilities
- Webpage: Full-Time Equivalent Capabilities
Video — A Seamless CRO Experience
![]() |
At Altasciences, our integrated, full-service solutions from lead candidate selection to clinical proof of concept are all customizable to your specific needs. Watch as Ingrid Holmes, Vice President, Global Clinical Operations, discusses how we help sponsors bring better drugs to market, faster. |
![]() |
Contact our experts to learn more about our integrated drug development solutions. |
The Right Strategy for your Small Molecule Program
The right CRO for your preclinical and clinical biosimilar studies
![]() |
||||||||||||||
Companies developing biosimilars are collaborating with us because of our firsthand preclinical and clinical experience, distinctive recruitment strategies and speed in conducting biosimilar studies that require a customized approach based on the therapeutic indication and study-specific goals. |
||||||||||||||
We have the scientific, toxicological, medical, and bioanalytical know-how to design studies that meet your objectives and timelines, manage any associated risks, and develop the methods required to analyze your product and its potential immunogenicity. |
||||||||||||||
How we help move your biosimilar programs forward: |
||||||||||||||
|
||||||||||||||
View our issue of The Altascientist on the topic and contact one of our experts to learn how we can help with your biosimilar programs. |
Supporting your Large Molecules ― from Discovery to Preclinical to Clinical Pharmacology
![]() |
Altasciences recently expanded its bioanalytical laboratory by adding space dedicated to ligand binding and cell-based assays, to continue to support and deliver quality bioanalytical solutions to our clients. The new, larger space is fully equipped to respond to the high demand of cell-based neutralization and functional assays for biologics and vaccines. We now have the additional capacity for cell lineage and functional immuno-phenotyping by flow cytometry to support both preclinical and clinical studies. |
![]() |
Bioanalytical Support for Your Large Molecules Renowned for our vast experience in LC-MS/MS and Ligand Binding bioanalytical platforms, our team of dedicated scientists in both the U.S. and Canada provide a comprehensive suite of bioanalytical services, from discovery to preclinical to phase IV. They evaluate each request and provide customized workflows to allow accurate quantitation using the appropriate platforms (Mass Spectrometry and/or Ligand Binding). Why do clients appreciate working with us? Because each bioanalytical phase of your study ― method development, validation, and sample analysis ― has a Method Development Expert and/or a Bioanalytical Principal Investigator with the appropriate scientific and regulatory expertise assigned. |
![]() |
Let's discuss your bioanalytical needs and how our solutions can support your preclinical and/or clinical research. |